Eric Adler serves as Executive at Lexeo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Eric Adler has executed 6 insider transactions totaling $38.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 18, 2025 involved selling 615 shares valued at $5.7K.
Eric Adler currently holds 72,646 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Adler has been a net seller of LXEO stock. They have purchased $0 and sold $38.8K worth of shares.
Eric Adler's most recent insider trade was on Nov 18, 2025, when they sold 615 shares at $9.27 per share.
Get notified when new Form 4 filings are submitted
| $8.94 |
| Discretionary |
| Oct 17, 2025 | LXEO | $363 | Sale | 38 | $9.56 | Discretionary |
| Oct 15, 2025 | LXEO | $0 | Award | 9,570 | $N/A | Discretionary |
| Aug 18, 2025 | LXEO | $2.8K | Sale | 608 | $4.67 | Discretionary |
| Feb 2, 2024 | LXEO | $0 | Award | 26,875 | $N/A | Discretionary |